Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.51
-0.29 (-3.72%)
Jan 2, 2026, 2:22 PM EST - Market open

BioCryst Pharmaceuticals Revenue by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Orladeyo
574.34M531.59M483.04M437.66M404.36M373.72M346.44M325.99M
Orladeyo Growth
42.04%42.24%39.43%34.26%32.21%30.61%28.15%29.55%
Other
25.47M25.92M20.45M13.05M8.22M8.51M8.95M5.42M
Other Growth
209.82%204.45%128.43%140.72%-29.82%-58.49%-53.71%-71.75%

Revenue by Type

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Product
593.30M551.63M497.18M442.67M404.06M373.29M345.80M324.70M
Product Growth
46.83%47.78%43.78%36.33%29.50%23.63%20.77%21.29%
Collaborative and Other
6.52M5.88M6.30M8.04M8.52M8.95M9.59M6.72M
Collaborative and Other Growth
-23.43%-34.31%-34.31%19.77%53.86%90.65%186.19%115.46%

Revenue by Geography

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
509.03M470.58M426.15M385.96M358.41M330.57M307.48M288.36M
United States Growth
42.02%42.36%38.60%33.85%31.50%28.43%26.39%27.39%
Outside of US
65.32M61.00M56.88M51.70M45.94M43.15M38.97M37.63M
Outside of US Growth
42.17%41.37%45.98%37.39%38.00%50.14%43.94%48.88%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.